Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
11/2010
11/10/2010EP2248807A1 N-phenyl-2-pyrimidine-amine derivatives
11/10/2010CN101880277A Aza spiro alkane derivatives as inhibitors of metallproteases
11/09/2010US7829711 treating HIV or AIDS; viral diseases; purity
11/09/2010US7829597 preventing the formation of insoluble A beta and arresting the production of A beta; beta-site amyloid precursor protein-cleaving enzyme; 3-[(2-amino-2-methyl-3-phenylpropoxy)methyl]-N-[(1R)-1-(4-fluorophenyl)ethyl]-[methyl(methylsulfonyl)amino]benzamide
11/09/2010US7829569 crystalline form of trans-1 {4-[2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl]-cyclohexyl}-3,3-dimethyl-urea hydrochloride (Form III) Cariprazine {RGH-188); Dysfunction of the dopaminergic neurotransmitter system is involved in the pathology of several neuropsychiatric and neurodegenerative disorders
11/09/2010US7829565 such as 5-{4-[4-(5-cyano-2,3-dihydro-1H-indol-3-yl)butyl]piperazin-1-yl}benzo-furan-2-carboxamide, used as antidepressant, anxiolytic, neuroleptic and/or hyportensive agents and for treating headaches, tardive dyskinesia, obsessive compulsive, sleep, eating, sexual and/or learning disorders
11/09/2010US7829564 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/09/2010US7829560 such as N-(4-{[2-(4-Ethylpiperazin-1-yl)pyrimidin-4-yl]oxy}-1-naphthyl)-3-fluoro-5-piperidin-1-ylbenzamide, useful as antiproliferative agents or in treating arthritis, osteoarthritis, Crohn's disease, ulcerative colitis, inflammatory bowel disease, psoriasis, autoimmune or inflammatory diseases
11/09/2010US7829257 Alkaline developable photoresists
11/09/2010CA2520297C Mass labels
11/09/2010CA2498122C Process for the preparation of 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy) quinazoline
11/09/2010CA2434937C Phenyl derivatives
11/09/2010CA2434028C Amino ceramide-like compounds and therapeutic methods of use
11/04/2010WO2010127190A1 Salt of abt-263 and solid-state forms thereof
11/04/2010WO2010125923A1 Polymer-supported catalyst and method for producing aromatic hetero compound using the catalyst
11/04/2010WO2010125831A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/04/2010WO2010125135A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010WO2010125134A1 N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010US20100280034 Modulation of pathogenicity
11/04/2010US20100280024 Renin inhibitors
11/04/2010US20100280018 Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
11/04/2010US20100280014 N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010US20100279997 Analgesic that binds filamin a
11/04/2010US20100279340 Imaging agents for protein misfolding
11/04/2010CA2759491A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010CA2759482A1 N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010CA2758740A1 Salt of abt-263 and solid-state forms thereof
11/04/2010CA2757761A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/03/2010EP2245015A1 Difluorinated tripeptides as hcv serine protease inhibitors
11/03/2010EP1831179B1 Method for the production of onium salts with tetrafluoroborate anion having a reduced halide content
11/03/2010EP1745002B1 Novel compounds, their preparation and use
11/03/2010EP1496838B1 Substituted amides
11/03/2010CN1615295B Compounds for treatment of inflammation, diabetes and related disorders
11/03/2010CN101878204A Novel carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/03/2010CN101875654A Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
11/03/2010CN101875617A Carbamyl aromatic acid compound with alkoxy replacing aromatic ring, preparation method and application thereof
11/03/2010CN101874798A Difunctional inhibitor of leukotriene A4 hydrolase and cyclooxygenase and application thereof
11/03/2010CN101293880B Synthesizing method for preparing N-acryloyl morpholine
11/02/2010US7825264 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
11/02/2010US7825247 an N-phenyl-4-(4-methyl-piperazin-1-ylmethyl)-benzamide claimed intermediate easily prepared by amidation of the aniline and the benzoic acid; reaction with a 2-aminopyrimidine to produce antitumor tyrosine kinase inhibitor
11/02/2010US7825120 tert-butyl 4-{[3-({[(6-methyl-3-pyridyl)amino]carbonylamino}methyl)phenyl]methyl}-piperazinecarboxylate; selectively modulates the cardiac sarcomere, for example by potentiating cardiac myosin, and may be useful in the treatment of systolic heart failure including congestive heart failure
11/02/2010CA2470391C N,n'-disubstituted piperazine compounds and their use as analgesics
11/02/2010CA2400167C Insecticidal anthranilamides
11/02/2010CA2389681C Npy y5 antagonist
10/2010
10/28/2010WO2010123960A2 Arylsulfonamide ccr3 antagonists
10/28/2010WO2010123956A2 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010US20100274008 Method for the production of an amine
10/28/2010US20100273883 Novel ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
10/28/2010US20100273798 Processes for the preparation of rivaroxaban and intermediates thereof
10/28/2010US20100273785 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010US20100273782 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/28/2010CA2758985A1 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010CA2758968A1 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010CA2758729A1 Arylsulfonamide ccr3 antagonists
10/27/2010EP2243774A1 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
10/27/2010CN1668303B Selective estrogen receptor modulators containing a phenylsulfonyl group
10/27/2010CN101874018A N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
10/27/2010CN101870696A N-aryl piperazine derivative having double activity of dopamine D2 and 5-HT2a
10/27/2010CN101870683A Method for preparing pinaverium bromide and intermediate compound of pinaverium bromide
10/27/2010CN101869824A Flue gas desulfurizing agent and flue gas desulfurization method
10/27/2010CN101175738B Apoptosis promoters
10/26/2010US7820846 by phosgenation of an aminobenzoylsulfamic acid amide intermediate; prepared from a p-nitrobenzoyl chloride or benzoate and a sulfamic acid amide and reducing the nitrobenzoylsulfamic acid amide; isocyanates are crop protection agents
10/26/2010US7820680 HIV integrase inhibitors
10/26/2010US7820675 Benzofuran compounds
10/26/2010US7820658 such as 2-Amino-4-phenyl-thieno[2,3-d]pyrimidine-6-carboxylic acid ethylamide; veterinary medicine; anticancer agents
10/26/2010US7820641 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2396956C Polypharmacophoric agents
10/21/2010WO2010119992A1 Derivatives of n-acyl-n'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
10/21/2010WO2010119877A1 Process for production of amidine derivative
10/21/2010WO2010118968A1 No-donor aspirin derivatives
10/21/2010WO2010086878A3 Thyroid receptor modulators
10/21/2010WO2009122445A3 Donor- acceptor fluorene scaffolds : a process and uses thereof
10/21/2010WO2009118516A8 Process for the preparation of donepezil hydrochloride
10/21/2010US20100267945 Amine derivative having npy y5 receptor antagonistic activity
10/21/2010US20100267737 4-phenylpiperazine derivatives with functionalized linkers as dopamine d3 receptor selective ligands and methods of use
10/21/2010US20100267726 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
10/21/2010US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
10/21/2010US20100266681 Fatty acid alcohols
10/21/2010CA2758895A1 Derivatives of n-acyl-n'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
10/20/2010EP2240458A1 Aryl sulfonamides as effective analgesics
10/20/2010EP2240447A2 Morpholine derivates as antiobesity agents
10/20/2010EP1780197B1 5-substituted-2-phenylamino benzamides as mek inhibitors
10/20/2010EP1381357B1 Glycyrrhetinic acid derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity
10/20/2010EP1317431B1 Polyarylcarboxamides useful as lipid lowering agents
10/20/2010EP1308438B1 3-substituted urea derivatives and medicinal use thereof
10/20/2010CN101863860A Synthesis method of 2-fluorine-4-substituted aminoaniline
10/20/2010CN101863786A Water-soluble shikonin naphthazarin oxygen nucleus alkyl derivative and preparation and application methods thereof
10/20/2010CN101862683A Novel process for preparing ethylenediamine product and catalyst thereof
10/19/2010US7816557 Glucagon receptor antagonists, preparation and therapeutic uses
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816530 cis- or trans-4-(4-cyclopropylmethyl-piperazin-1-yl)-cyclohexylamine; antiinflammatory and antiproliferative activity; antiviral and anticarcinogenic agent
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816359 such as (4-[(4-methyl-1-piperazin-1-ylmethyl)-N-[4-methyl-3-[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide), used as antitumor agents
10/19/2010US7816358 Pharmaceutical formulations comprising N,N′-disubstituted piperazine compounds
10/19/2010US7816355 Processes for the preparation of rivaroxaban and intermediates thereof
10/19/2010CA2419023C Catalyst for aromatic c-o, c-n, and c-c bond formation
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 341